Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 90
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02188277 | Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy | ||
| NCT06381999 | Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool | ||
| NCT04622254 | Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines | ||
| NCT02207946 | Botulinum Toxin A to Treat Arm Tremor | ||
| NCT00429520 | Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds | ||
| NCT00712283 | Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers | ||
| NCT01910896 | Effectiveness and Safety Study of Overnight Intensive Patch in Scars | ||
| NCT00649220 | Memantine and Antipsychotics Use | ||
| NCT01112371 | Contractubex Treatment in Scars After Abdominal Caesarean Section | ||
| NCT01109680 | A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects | ||
| NCT03992404 | Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury | ||
| NCT00512135 | Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines | ||
| NCT03986424 | Local Study of Akatinol Memantine in VaD in Russia | ||
| NCT04908423 | Xeomin® and Gait Related Mobility After Stroke | ||
| NCT00507637 | Blepharospasm Short Interval | ||
| NCT04210258 | Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face | ||
| NCT00407030 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia | ||
| NCT00432666 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb | ||
| NCT03119948 | Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis | ||
| NCT00936026 | Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane | ||
| NCT01905683 | Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy | ||
| NCT00465738 | IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity | ||
| NCT00915174 | Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects | ||
| NCT00799942 | Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus | ||
| NCT00909883 | Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease : Efficiency of Injections Made in Extrinsic Muscle (Flexor Digitorum Longus Muscle) Compared to Intrinsic Muscle (Flexor Digitorum Brevis or Quadratus Plantae Muscles) | ||
| NCT00541723 | Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles | ||
| NCT04075981 | Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) | ||
| NCT01405482 | Botulinum Toxin Injections for Thoracic Outlet Syndrome | ||
| NCT06995287 | Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Pelvic Pain Suggestive of Dysmenorrhea | ||
| NCT00955799 | Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus | ||
| NCT00624026 | Memantine - Communication Study | ||
| NCT01515371 | Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring | ||
| NCT00430586 | Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines | ||
| NCT00955760 | Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate | ||
| NCT07018700 | A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine | ||
| NCT05623111 | Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities | ||
| NCT00983099 | Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects | ||
| NCT00661440 | Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus | ||
| NCT03806933 | Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines | ||
| NCT02577224 | An RCT of a Patient-initiated Treatment Service for BEB and HFS | ||
| NCT02091739 | Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions | ||
| NCT00872898 | Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism | ||
| NCT00770211 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines | ||
| NCT03650387 | Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face | ||
| NCT04177212 | Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles | ||
| NCT01603459 | Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm | ||
| NCT00804271 | Memantine and Validation of a New Alzheimer's Disease Scale | ||
| NCT00515944 | Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products | ||
| NCT00770029 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2 | ||
| NCT01305187 | Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3 |
